Turiel Guillermo, Desgeorges Thibaut, Masschelein Evi, Fan Zheng, Lussi David, Capelle Christophe M, Bernardini Giulia, Ardicoglu Raphaela, Schönberger Katharina, Birrer Manuela, Fucentese Sandro F, Zhang Jing, Latorre Daniela, Engelberger Stephan, De Bock Katrien
Laboratory of Exercise and Health, Department of Health Sciences and Technology, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.
Institute of Anatomy, University of Zurich, Zurich, Switzerland.
Nat Cardiovasc Res. 2025 Sep 15. doi: 10.1038/s44161-025-00709-y.
Peripheral artery disease (PAD) results from atherosclerosis and chronic narrowing of lower limb arteries, leading to decreased muscle perfusion. Current treatments are suboptimal, partly due to limited understanding of PAD muscle pathology. Here we used single-cell RNA sequencing and spatial transcriptomics to analyze the composition of the muscle microenvironment in non-ischemic patients and patients with PAD. We identified ATF3/ATF4 endothelial cells (ECs) that exhibit altered angiogenic and immune regulatory profiles during PAD and confirmed that ATF4 signaling in ECs is required for effective ischemia recovery. In addition, capillary ECs display features of endothelial-to-mesenchymal transition. Furthermore, LYVE1MHCII macrophages are the dominant macrophage population in human muscle, adopting a more pro-inflammatory profile during PAD. Finally, we analyzed alterations in intercellular communication within the muscle microenvironment during PAD and confirmed that EC-derived factors can influence macrophage polarization. This dataset deeply characterizes the PAD muscle microenvironment and provides a resource for exploration of targeted therapies.
外周动脉疾病(PAD)是由动脉粥样硬化和下肢动脉慢性狭窄引起的,导致肌肉灌注减少。目前的治疗方法并不理想,部分原因是对PAD肌肉病理学的了解有限。在这里,我们使用单细胞RNA测序和空间转录组学来分析非缺血患者和PAD患者肌肉微环境的组成。我们鉴定出在PAD期间血管生成和免疫调节谱发生改变的ATF3/ATF4内皮细胞(ECs),并证实ECs中的ATF4信号是有效缺血恢复所必需的。此外,毛细血管ECs表现出内皮向间充质转化的特征。此外,LYVE1MHCII巨噬细胞是人类肌肉中的主要巨噬细胞群体,在PAD期间呈现出更具促炎的特征。最后,我们分析了PAD期间肌肉微环境中细胞间通讯的变化,并证实EC衍生因子可以影响巨噬细胞极化。该数据集深入表征了PAD肌肉微环境,并为探索靶向治疗提供了资源。